संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

unit dose services - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 100 mg - sumatriptan tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. sumatriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see contraindications ). safety and effectiveness of sumatriptan tablets have not been established for cluster headache, which is present in an older, predominantly male population. sumatriptan tablets should not be given to patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes. in addition, patients with other significant underlying cardiovascular diseases should not receive sumatriptane tablets. ischemic cardiac syndromes include, but are not limited to, angina pectoris of any type (e.g., stable angina of effort, vasospastic forms of angina such as the prinzmetal variant), all forms of myocardial infarction, and silent myocardial ischemia. cerebrovascular syndromes include, but are not limited to, stro

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

preferred pharmaceuticals, inc - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 25 mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 6.5 mg in 4 h

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

unit dose services - frovatriptan succinate (unii: d28j6w18hy) (frovatriptan - unii:h82q2d5wa7) - frovatriptan 2.5 mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

endo pharmaceuticals, inc. - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 6 mg in 0.5 ml

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

avanir pharmaceuticals, inc. - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 11 mg - onzetra®  xsail®  is indicated for the acute treatment of migraine with or without aura in adults. limitations of use - use only if a clear diagnosis of migraine has been established. if a patient has no response to the first migraine attack treated with onzetra xsail, reconsider the diagnosis of migraine before treatment of subsequent attacks with onzetra xsail. - onzetra xsail is not indicated for the prevention of migraine attacks. - safety and effectiveness of onzetra xsail have not been established for the treatment of cluster headache.  onzetra xsail is contraindicated in patients with: - ischemic coronary artery disease (cad) (e.g., angina pectoris, history of myocardial infarction, or silent ischemia) or coronary artery vasospasm, including prinzmetal's angina or in patients with other significant underlying cardiovascular diseases [ see warnings and precautions (5.1) ].   - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders  [ see war

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

sagent pharmaceuticals - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 6 mg in 0.5 ml

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

teva parenteral medicines, inc. - sumatriptan succinate (unii: j8bdz68989) (sumatriptan - unii:8r78f6l9vo) - sumatriptan 6 mg in 0.5 ml - sumatriptan succinate injection is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache. limitations of use: - use only if a clear diagnosis of migraine or cluster headache has been established. if a patient has no response to the first migraine or cluster headache attack treated with sumatriptan succinate injection, reconsider the diagnosis before sumatriptan injection is administered to treat any subsequent attacks. - sumatriptan succinate injection is not indicated for the prevention of migraine or cluster headache attacks. sumatriptan succinate injection is contraindicated in patients with: - ischemic coronary artery disease (cad) (angina pectoris, history of myocardial infarction, or documented silent ischemia) or coronary artery vasospasm, including prinzmetal’s angina [see warnings and precautions (5.1)] . - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

sun pharmaceutical industries limited - naratriptan hydrochloride (unii: 10x8x4p12z) (naratriptan - unii:qx3kxl1za2) - naratriptan 2.5 mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

paddock laboratories, llc - naratriptan hydrochloride (unii: 10x8x4p12z) (naratriptan - unii:qx3kxl1za2) - naratriptan 1 mg